Achieve Life Sciences, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Achieve Life Sciences, Inc. (ACHV) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $17.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-24
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $17.00K.
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was -$44.00K, a 540.00% decline from fiscal 2023.
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $10.00K, a 80.39% decline from fiscal 2022.
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $51.00K, a 537.50% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $17.00K 10-K · filed 2026-03-24 | |
| 2024-12-31 | -$44.00K 10-K · filed 2026-03-24 | -$112.00K 10-K · filed 2025-03-11 |
| 2023-12-31 | $10.00K 10-K · filed 2026-03-24 | -$54.00K 10-K · filed 2024-03-28 |
| 2022-12-31 | $51.00K 10-K · filed 2025-03-11 | |
| 2021-12-31 | $8.00K 10-K · filed 2024-03-28 | |
| 2020-12-31 | -$594.00K 10-K · filed 2023-03-16 | -$76.00K 10-K · filed 2021-03-11 |
| 2019-12-31 | -$179.00K 10-K · filed 2022-03-10 | -$104.00K 10-K · filed 2020-03-13 |
| 2018-12-31 | -$27.00K 10-K · filed 2021-03-11 | |
| 2017-12-31 | -$14.00K 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |